HomepageABCL • NASDAQ
add
AbCellera Biologics Inc
Vorige slotkoers
$Â 3,48
Dag-range
$Â 3,27 - $Â 3,46
Jaar-range
$Â 2,34 - $Â 5,62
Beurswaarde
985,05Â mln. USD
Gem. volume
3,45Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 6,51Â mln. | -1,39% |
Bedrijfskosten | 59,20Â mln. | 151,15% |
Netto inkomsten | -51,11Â mln. | -78,63% |
Netto winstmarge | -785,42 | -81,16% |
Winst per aandeel | -0,17 | -70,00% |
EBITDA | -56,74Â mln. | -15,44% |
Effectief belastingtarief | 18,40% | — |
Balans
Totale activa
Totale passiva
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 643,14Â mln. | -18,16% |
Totale activa | 1,39Â mld. | -7,89% |
Totale passiva | 314,73Â mln. | -4,46% |
Totaal aandelenvermogen | 1,08 mld. | — |
Uitstaande aandelen | 295,37 mln. | — |
Koers-boekwaardeverhouding | 0,95 | — |
Rendement op activa | -16,69% | — |
Rendement op kapitaal | -20,08% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -51,11Â mln. | -78,63% |
Operationele kasstroom | -28,88Â mln. | -27.147,17% |
Kasstroom uit beleggingen | 3,70Â mln. | 128,92% |
Kasstroom uit financiering | 3,14Â mln. | -52,56% |
Nettomutatie in liquide middelen | -21,67Â mln. | -195,86% |
Vrije kasstroom | -10,48Â mln. | 72,64% |
Over
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Opgericht
2012
Hoofdvestiging
Website
Werknemers
586
